Listed by the USPTO as GONZALEZ, LEI NMN
Tech Center 3700 • Art Units: 3783
This examiner grants 43% of resolved cases
GONZALEZ, LEI NMN is assigned to tech center 3700 and art unit 3783. The profile contains 21 resolved cases, with a 42.9% allowance rate and a median of 1449 days to allowance. The limited case base means practitioners should use these figures as directional information when assessing potential prosecution paths.
The interview lift is 51.8%, associating interviews with a substantially better allowance outcome in the available record. Counsel may consider early interviews supported by concrete claim proposals and technical explanations. The listed companies are Becton, Dickinson and Company, Cardinal Health Inc., and Insulet Corporation. The leading firms are Goodwin Procter LLP, Maschoff Brennan (OC)(BD), and Bond, Schoeneck & King, PLLC - SANOFI.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17716675 | Catheter Placement System with Splittable Anchor | Final Rejection | Bard Access Systems, Inc. |
| 18157569 | HYBRID TRANSSEPTAL DILATOR AND METHODS OF USING THE SAME | Non-Final OA | Boston Scientific Medical Device Limited |
| 18020386 | INGESTIBLE DRUG DELIVERY DEVICE | Non-Final OA | Novo Nordisk A/S |
| 18209120 | INFUSION PUMP | Final Rejection | TERUMO KABUSHIKI KAISHA |
| 18530918 | NEEDLE-FREE CONNECTORS | Non-Final OA | CareFusion 303, Inc. |
| 18353606 | FLOW RESTRICTION ADAPTER FOR RESTRICTING HEMOLYSIS | Non-Final OA | CareFusion 303, Inc. |
| 17982489 | INTRAVENOUS SET CORKSCREW HAND PUMP | Non-Final OA | CareFusion 303, Inc. |
| 18055895 | AUTO-INJECTOR AND RELATED METHODS OF USE | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18037139 | FORMULATIONS, METHODS, AND PRE-FILLED INJECTION DEVICES WITHOUT FATTY ACID PARTICLES | Non-Final OA | W. L. Gore & Associates, Inc. |
| 17945585 | BIOACTIVE RELEASING MEMBRANE FOR ANALYTE SENSOR | Non-Final OA | DexCom, Inc. |
| 18203127 | Container Closure with Reverse Coefficient of Thermal Expansion Materials | Final Rejection | Becton, Dickinson and Company |
| 17967323 | Self-Calibration for Pump Operation of Medical Injector | Non-Final OA | Becton, Dickinson and Company |
| 17901034 | Instrument Delivery Device with Linearly Compressible Housing | Final Rejection | Becton, Dickinson and Company |
| 17808427 | USER REMOVABLE FILL CLOSURE TAB WITH INTEGRATED MEMBRANE | Non-Final OA | Becton, Dickinson and Company |
| 17597815 | Improved Flow Channel for Flow Rate Measurement | Non-Final OA | Becton, Dickinson and Company |
| 18454323 | SYSTEM AND METHOD FOR ADJUSTING INSULIN DELIVERY TO ACCOUNT FOR INSULIN RESISTANCE | Final Rejection | INSULET CORPORATION |
| 18306041 | COMPRESSION DETECTION AND COMPENSATION FOR A BIOLOGICAL SENSOR SECURED TO A USER | Final Rejection | Insulet Corporation |
| 17921276 | Supplemental Device for an Injection Device | Final Rejection | Sanofi |
| 18703140 | AN INFUSION SUBASSEMBLY AND AN INFUSION ASSEMBLY | Non-Final OA | SHL Medical AG |
| 18575771 | Optimized Port Stem Geometry | Non-Final OA | Bard Peripheral Vascular, Inc. |
| 18235113 | DECOMPRESSION NEEDLE ASSEMBLY | Non-Final OA | North American Rescue, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy42.9% of resolved applications examined by Lei Nmn Gonzalez were allowed (21 resolved cases), compared with 67.3% across Art Unit 3783 over the last five years.
This examiner's interview lift is +51.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Lei Nmn Gonzalez took 1,449 days on average from filing to allowance.
Lei Nmn Gonzalez examines applications in Art Unit 3783 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
